Pancreatic exocrine insufficiency: Comparing fecal elastase 1 with 72-h stool for fecal fat estimation. 2016

Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
Division of Gastrointestinal Sciences, Christian Medical College, Vellore, 632 004, India. sudipto.d.c@gmail.com.

BACKGROUND Identification of pancreatic exocrine insufficiency (PEI) is important in the management of chronic pancreatitis. The 72-h stool for fecal fat estimation (FFE) has long been considered a gold standard indirect test for the diagnosis of PEI. However, the test is cumbersome for both patients and laboratory personnel alike. In this study, we aimed to assess fecal elastase 1 (FE1) as an alternate to FFE for the diagnosis of PEI. METHODS In all, 87 consecutive patients diagnosed with chronic pancreatitis were included in this study. FFE and FE1 estimation was done for all the patients. For FE1, two cutoffs (<100 and <200 μg) were selected to define pancreatic exocrine insufficiency. The sensitivity, specificity, and positive and negative predictive values for the two cutoffs were estimated. Kappa statistics was used to assess degree of agreement between both tests. RESULTS All patients completed the study and were included in the analysis. The sensitivity, specificity, and positive and negative predictive value and PABAK (prevalence and bias adjusted kappa) for FE1 <100 μg was 84.9, 47.6, 83.6, 50, and 0.52, respectively. For FE1 <200 μg, it was 90.9, 9.5, 75.95, 25, and 0.43, respectively. CONCLUSIONS FE1 is a sensitive test; however, it does not have a good agreement with FFE. FE1 may be used as screening test for PEI in patients with chronic pancreatitis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010188 Exocrine Pancreatic Insufficiency A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS. Pancreatic Insufficiency,Exocrine Pancreatic Insufficiencies,Insufficiencies, Exocrine Pancreatic,Insufficiencies, Pancreatic,Insufficiency, Exocrine Pancreatic,Insufficiency, Pancreatic,Pancreatic Insufficiencies,Pancreatic Insufficiencies, Exocrine,Pancreatic Insufficiency, Exocrine
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005223 Fats The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet (DIETARY FATS) as a source of energy. (Grant & Hackh's Chemical Dictionary, 5th ed)
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
September 2006, Journal of gastroenterology,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
May 2017, Digestive diseases and sciences,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
January 2011, ISRN gastroenterology,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
January 2019, Gastroenterology research and practice,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
July 2022, Clinical laboratory,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
February 1983, Klinische Wochenschrift,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
March 2005, Pancreas,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
April 2008, Pancreas,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
January 2020, Therapeutic advances in gastroenterology,
Sudipta Dhar Chowdhury, and Reuben Thomas Kurien, and Anup Ramachandran, and Anjilivelil Joseph Joseph, and Ebby George Simon, and Amit Kumar Dutta, and Deepu David, and Bharath Kumar C, and Prassana Samuel, and K A Balasubramaniam
April 2019, Pancreas,
Copied contents to your clipboard!